These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 35456656)
1. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer. Cai Y; Zhang L; Zhang Y; Lu R Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456656 [TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated macrophage regulation for inflammatory bowel disease repair: a potential target of gut inflammation. Ma F; Zhang S; Akanyibah FA; Zhang W; Chen K; Ocansey DKW; Lyu C; Mao F Am J Transl Res; 2023; 15(12):6970-6987. PubMed ID: 38186999 [TBL] [Abstract][Full Text] [Related]
3. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Karthikeyan A; Young KN; Moniruzzaman M; Beyene AM; Do K; Kalaiselvi S; Min T Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918207 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. Yang C; Merlin D Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785 [TBL] [Abstract][Full Text] [Related]
5. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Gao C; Liu L; Zhou Y; Bian Z; Wang S; Wang Y Chin Med; 2019; 14():23. PubMed ID: 31236131 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382 [TBL] [Abstract][Full Text] [Related]
7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
8. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Fantini MC; Guadagni I Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800 [TBL] [Abstract][Full Text] [Related]
9. Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease. Li DF; Tang Q; Yang MF; Xu HM; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Wang JY; Liang YJ; Wang LS; Yao J Nanoscale Adv; 2023 Jul; 5(14):3575-3588. PubMed ID: 37441251 [TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire. Suh JH; Saba JD Transl Cancer Res; 2015 Oct; 4(5):469-483. PubMed ID: 27011900 [TBL] [Abstract][Full Text] [Related]
11. Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment. Fang X; Feng J; Zhu X; Feng D; Zheng L Mol Ther; 2024 Apr; 32(4):890-909. PubMed ID: 38369751 [TBL] [Abstract][Full Text] [Related]
12. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
13. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations. Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338 [TBL] [Abstract][Full Text] [Related]
14. Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease. Li X; Lu C; Yang Y; Yu C; Rao Y Biomed Pharmacother; 2020 Sep; 129():110486. PubMed ID: 32768972 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313 [TBL] [Abstract][Full Text] [Related]
16. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Duan L; Cheng S; Li L; Liu Y; Wang D; Liu G Front Pharmacol; 2021; 12():684486. PubMed ID: 34335253 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Jacob EM; Borah A; Pillai SC; Kumar DS Nanomaterials (Basel); 2020 Dec; 10(12):. PubMed ID: 33316984 [TBL] [Abstract][Full Text] [Related]
18. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases. Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Guo G; Tan Z; Liu Y; Shi F; She J Stem Cell Res Ther; 2022 Apr; 13(1):138. PubMed ID: 35365226 [TBL] [Abstract][Full Text] [Related]
20. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review. Jakubczyk D; Leszczyńska K; Górska S Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]